Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells - Test2 - elhamkhani - TriplyDB

Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells

Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells

http://www.wikidata.org/entity/Q35786924

about

Overexpression of the duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis Chemokines as mediators of tumor angiogenesis and neovascularization CXC chemokines in cancer angiogenesis and metastases Snail promotes CXCR2 ligand-dependent tumor progression in non-small cell lung carcinoma Chemokines as mediators of neovascularization Variations of proline-rich kinase Pyk2 expression correlate with prostate cancer progression.Modulation of CXCL14 (BRAK) expression in prostate cancer.ELR+ CXC chemokine expression in benign and malignant colorectal conditions The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cells Epigallocatechin-3-gallate suppresses proinflammatory cytokines and chemokines induced by Toll-like receptor 9 agonists in prostate cancer cells.Distribution of Duffy Antigen Receptor for Chemokines (DARC) and Risk of Prostate Cancer in Barbados, West Indies Role of Chemokines and Chemokine Receptors in Prostate Cancer Development and Progression CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis Targeting PPARγ Signaling Cascade for the Prevention and Treatment of Prostate Cancer.Chemokines and antitumor immunity: walking the tightrope.Secretome analysis of an osteogenic prostate tumor identifies complex signaling networks mediating cross-talk of cancer and stromal cells within the tumor microenvironment A role for aberrantly expressed nuclear localized decorin in migration and invasion of dysplastic and malignant oral epithelial cells.Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopes.Activated human valvular interstitial cells sustain interleukin-17 production to recruit neutrophils in infective endocarditis Recent advances in underlying pathologies provide insight into interleukin-8 expression-mediated inflammation and angiogenesis.Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia Association between preeclampsia and the CXC chemokine family (Review).Diversity of the angiogenic phenotype in non-small cell lung cancer.CXCL5 promotes prostate cancer progression CXC chemokines and prostate cancer: growth regulators and potential biomarkers.UNBS5162, a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers Chemokines and chemokine receptors as promoters of prostate cancer growth and progression.Prostaglandin F2alpha-F-prostanoid receptor signaling promotes neutrophil chemotaxis via chemokine (C-X-C motif) ligand 1 in endometrial adenocarcinoma Depletion of intrinsic expression of Interleukin-8 in prostate cancer cells causes cell cycle arrest, spontaneous apoptosis and increases the efficacy of chemotherapeutic drugs.Polymorphisms of pro-inflammatory genes and prostate cancer risk: a pharmacogenomic approach.Targeted knockdown of EGR-1 inhibits IL-8 production and IL-8-mediated invasion of prostate cancer cells through suppressing EGR-1/NF-kappaB synergy.The role of chemokines and their receptors in angiogenesis.The role of CXC chemokines and their receptors in the progression and treatment of tumors.Rationale and Means to Target Pro-Inflammatory Interleukin-8 (CXCL8) Signaling in Cancer.Differential expression of interleukin-8 and its receptors in the neuroendocrine and non-neuroendocrine compartments of prostate cancer.Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets.Overexpression of CXCL3 can enhance the oncogenic potential of prostate cancer.Inflammatory microenvironment and expression of chemokines in hepatocellular carcinoma Proteomic signatures of angiogenesis in androgen-independent prostate cancer.Impact of CXCL1 overexpression on growth and invasion of prostate cancer cell.

P2860

Q24804267-831889A8-68FE-46E0-A95C-FD58E9DEDC68 Q30427886-FC3A6D82-27FC-4BCA-8E78-8B69C595F873 Q30432791-EF42F72E-44F1-4C01-91F1-55FEBE2BBFC9 Q30434154-9801B136-84CC-4A88-BC5E-650CB205CFA2 Q30438032-4B7A3081-10E5-427A-A3BA-BDE8A1461439 Q32005910-690F6662-37F7-48AE-8893-76517C821B30 Q33210882-A3233292-D468-415C-83DC-1A14220DEE5A Q33346619-11E69ADD-8AAC-4B03-AE7A-5EE60BE98EAE Q33592512-A8ACA9F8-B87B-42C7-BFB6-9FD9A014B2E6 Q33806328-C9E6D4F3-2D81-4627-839D-C1C376726BAF Q33864788-700EE5B3-DA21-4B93-A514-58586F70A5E7 Q34090617-296D6617-0A7F-40E5-8505-88E89A4238FA Q34095143-7583E5F3-9C00-4674-A175-59DAF98F1DB0 Q34646050-48E72E4C-085B-4ACB-B797-1DCC01A305FB Q35126970-FBF7CDCC-340B-45C1-96EB-0D75633A4E6C Q35148340-07752F1D-D462-4CFE-865B-4BB9C2F46752 Q35413739-F836B14E-1910-4892-BFF3-1FFFBF731BF9 Q35498810-CA083491-C645-4260-9246-569AE454C2DB Q35609357-8AFD6242-CA99-4BB6-B55D-866927FDB8A4 Q35659991-BBB7AA49-D384-4D9D-849A-3271D459E1CA Q35746575-5BE50F1F-8EF5-4E8E-AC2C-716D53411E5B Q35753903-DAA4F84E-FC02-424C-AB1A-9A9141472DC9 Q35855285-6BD9C0B2-980F-432C-9BFA-2F9AC5180A66 Q36487549-83FEAE31-9F5C-4565-9F1A-A21B66D7014C Q36616524-B3286EAC-30CB-4DB8-AB07-6192715B4B2F Q36661715-3FE8711B-58E4-4DA8-92F3-048AE67F9E97 Q37078475-0716995A-2957-49AA-A6B8-72CEF2F857C6 Q37266333-824FBBA9-BE38-49D9-AA0C-B7DD4C7F7446 Q37312692-00A8FB52-4094-4B93-AC6E-959938523ABD Q37394643-3EF9C21E-0D3D-4854-8DDF-F5A89CDE4508 Q37454167-3EB803E8-6A7C-4312-8A3B-EFCE098E3D6F Q37863514-C02AD7DF-4E4B-4AB1-9587-B01FFA538197 Q38023245-ADFA3756-DC30-4B37-851C-A2CADD3E27AD Q38166232-B85876C7-7103-4790-B675-FAAB9377C95D Q38586188-83F4CBD8-B6EA-459F-A198-B12DF578EDC2 Q38763251-632D0E13-FB11-434B-865F-4839022C077C Q38797305-C2427BA4-C4E2-40DF-9691-7458FA50F519 Q38878644-51A77A11-C88E-4516-9D1C-1C2222559DF9 Q39069308-61708C05-E452-49CE-9BB4-1EE3F94BE065 Q39207614-47D24EDA-4480-48FD-AEDC-22EE61CAF750

P2860

Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells

http://www.wikidata.org/entity/Q35786924

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

1999年论文

@zh

1999年论文

@zh-cn

name

Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells

@ast

Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells

@en

type

label

Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells

@ast

Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells

@en

prefLabel

Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells

@ast

Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells

@en

P1433

Q35786924-EE78C412-427E-41BB-9358-D4FC7D700A93

P1476

Q35786924-23268548-19F3-42BC-A5DC-C1413DCCCD1B

P2093

Q35786924-27657B5A-A8D9-43D4-AA88-098F379993F9

Q35786924-28BB707D-0B0F-46E8-9764-AB96EF6A2A4C

Q35786924-2CF3554A-0402-45B9-A566-C7A37EE9EAA8

Q35786924-68D2E4DA-81C7-49B7-83FF-9D4B8641A46A

Q35786924-89CBB0E0-5FEF-4A67-93D5-929230BE74E7

Q35786924-8A9C92EC-4EDF-4ED9-9FF7-A1B1594ACC8A

Q35786924-8AD77B1A-C5DE-4CD2-8CD7-5158E3E7E4B7

Q35786924-9CAF071A-EAEE-46D3-93BA-7890E3602DB6

Q35786924-A54F5E8A-84A5-49C3-A5B0-32FAABAA158E

Q35786924-BB2886C0-7C0C-40F0-A8AD-34736E2A22D6

P2860

Q35786924-0426E892-9050-4516-837A-194866B689E2

Q35786924-397A80EF-6E74-4F50-B953-F652E5E3A66A

Q35786924-3BD3BEDA-5EEA-4259-BFFC-D7277A109D6B

Q35786924-616FF636-2DA6-4073-99C7-E396ECE08078

Q35786924-64280110-A040-4222-A744-95068989F813

Q35786924-88063A1E-7984-4F71-93DC-A2F5A865A426

Q35786924-8BC24660-C061-4792-8658-BC90B883370A

Q35786924-8EE27BD9-EB01-4C90-A260-F0FCFD42661A

Q35786924-9B0C3E5F-00C8-47A8-819E-4D19ABB5AE8C

Q35786924-A3FC9589-EF44-4852-9621-C53ADDFF2979

P304

Q35786924-4A841F68-CD5C-4308-BC75-B2FBFC51FC9F

P31

Q35786924-D04C00FB-ECC6-4DF9-8E8A-8E10AECC330D

P356

Q35786924-124FDF07-51B3-4A63-9F7E-158AC5ED5584

P407

Q35786924-7B99A58C-3A92-46E9-9250-659BF7C88D6D

P433

Q35786924-080048C5-33F5-4FE9-BFEC-B67B7BDD8D3F

P478

Q35786924-8897871D-1044-4922-9EB5-5725BF99DD6B

P577

Q35786924-8A09FF06-0543-4ED6-A0F5-ECA76A013B2F

P698

Q35786924-DC4BCB40-CF3C-4D06-A5CC-1DE20DFE5AEC

P932

Q35786924-DFF4E6C7-D056-4249-A23C-FBA2570DA0C8

P356

S0002-9440(10)65404-1

P1433

The American Journal of Pathology

P1476

Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells

@en

P2093

B B Moore

http://www.w3.org/2001/XMLSchema#string

C L Addison

http://www.w3.org/2001/XMLSchema#string

C Wilke

http://www.w3.org/2001/XMLSchema#string

D A Arenberg

http://www.w3.org/2001/XMLSchema#string

K Stoy

http://www.w3.org/2001/XMLSchema#string

M D Burdick

http://www.w3.org/2001/XMLSchema#string

M Glass

http://www.w3.org/2001/XMLSchema#string

R M Strieter

http://www.w3.org/2001/XMLSchema#string

S B Morris

http://www.w3.org/2001/XMLSchema#string

S L Kunkel

http://www.w3.org/2001/XMLSchema#string

P2860

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

Structure and functional expression of a human interleukin-8 receptor

Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog

Long-term impaired neutrophil migration in mice overexpressing human interleukin-8.

Establishment and characterization of a human prostatic carcinoma cell line (PC-3).

LNCaP model of human prostatic carcinoma.

The functional role of the ELR motif in CXC chemokine-mediated angiogenesis.

Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines.

Expression of interleukin-8 correlates with vascularity in human gastric carcinomas.

Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique.

P304

1503-1512

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9440(10)65404-1

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

154

http://www.w3.org/2001/XMLSchema#string

P577

1999-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10329603

http://www.w3.org/2001/XMLSchema#string

P932

1866583

http://www.w3.org/2001/XMLSchema#string